id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0533-0008,FDA,FDA-2009-D-0533,"Guidance for Industry:  Recommendations for Blood Establishments; Availability: Training of Back-UpPersonnel, Assessment of Blood Donor Suitability, and Reporting Certain Changes to an Approved Application",Notice,NAD-Notice of Availability of Data,2010-12-03T05:00:00Z,2010,12,2010-12-03T05:00:00Z,,2010-12-03T19:53:33Z,2010-30388,0,0,0900006480bad6f5
FDA-2009-D-0533-0010,FDA,FDA-2009-D-0533,Ref. 1 - Guidance for Industry; Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further Manufacture,Supporting & Related Material,GDL-Guidance,2010-12-03T05:00:00Z,2010,12,,,2010-12-03T20:54:44Z,,0,0,0900006480bae5c8
FDA-2009-D-0533-0011,FDA,FDA-2009-D-0533,Ref. 2 - Guidance for Industry; Streamlining the Donor Interview Process: Recommendations for Self-Administered Questionnaires,Supporting & Related Material,GDL-Guidance,2010-12-03T05:00:00Z,2010,12,,,2010-12-03T20:52:40Z,,0,0,0900006480bae5ca
FDA-2009-D-0533-0009,FDA,FDA-2009-D-0533,"Guidance for Industry; Recommendations for Blood Establishments: Training of Back-Up Personnel, Assessment of Blood Donor Suitability and Reporting Certain Changes to an Approved Application",Other,Guidance,2010-11-01T04:00:00Z,2010,11,2010-11-01T04:00:00Z,,2024-11-07T22:29:32Z,,1,0,0900006480bae5c6